Prelude Therapeutics (PRLD) IPO Opens 33% Higher
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- CAE agrees to sell Flightscape unit to SITA for $500 million
IPO for Prelude Therapeutics (PRLD) Paused on Volatility After Ramp Higher
September 25, 2020 12:06 PM EDTToday's IPO for Prelude Therapeutics (NASDAQ: PRLD) was paused on volatility after ramping higher. Shares were last up 55% after opening up 33%.
... MorePrelude Therapeutics Inc. (PRLD) Prices 8.325M Share IPO at $19/Sh
September 25, 2020 6:17 AM EDTPrelude Therapeutics Incorporated (NASDAQ: PRLD) today announced the pricing of its initial public offering of 8,325,000 shares of its common stock at a public offering price of $19.00 per share. The gross proceeds to Prelude, before deducting underwriting commissions and offering expenses, are expected to be... More



